Crescent Biopharma, Inc. (CBIO)
NASDAQ·Healthcare·Biotechnology
$18.20
-0.76%
Mkt Cap $496.29M
Analyst Ratings
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
Implied Upside
+81.3%
Consensus $33.00 vs current $18.20
NASDAQ·Healthcare·Biotechnology
$18.20
-0.76%
Mkt Cap $496.29M
Buy
1
Hold
1
Sell
0
Price Target (5 analysts)
$33.00
Range $29.00 – $35.00
+81.3%
Consensus $33.00 vs current $18.20